CCL2 is a chemokine that mediates peripheral blood monocytes recruit into the arterial wall, resulting in neointima formation in atherosclerosis (32–35), and CCL2 deficiency reduces atherosclerotic plaque formation in mice of diverse genetic backgrounds (36, 37). Here, CCL2 is linked to atherosclerosis.